Juan Basterra

Health Engineering is a technology-based newly established company that emerges as a Spin Off of the University of Jaen in order to obtain in the short-term the CE marking as a biomarker for the early detection and monitoring of Multiple Sclerosis. This biomarker that we intend to turn in a diagnostic and monitoring standard is called FractalMed and would be the first commercial technology to determine the Fractal Dimension 3D applied to the diagnosis and monitoring of neurodegenerative diseases. Once obtained the CE marking a reference value for the early diagnosis and monitoring of the disease progression and the response to treatment will be stablished, enabling early interventions with consequent further reduction in the number of outbreaks and improved quality of life for patients. FractalMed has already done the proof of concept and clinical validation demonstrating in a cohort of patients that the Fractal Dimension can be applied as a criterion aid in early diagnosis and monitoring of Multiple Sclerosis. More information; www.fractalmed.com

Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome. Our vision We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure. Our values Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic solutions based on the human microbiome through excellence in its processes, empathising with chronic patients for whom no curative treatments are available, always from the perspective of networking with all stakeholders in the sector.

Orkestra is a research institute based in the Basque Country (Spain) that studies competitiveness and regional development from different research lines with three main goals: • Create knowledge of regional competitiveness • Promote the improvement of citizens'​ wellbeing • Contribute to the improvement of the Basque Country's competitiveness Orkestra’s team drives transforming research, defined by analysis, reflection, evaluation and the proposal of actions in a permanent form aimed at providing innovative answers for challenge resolutions, while research knowledge is acquired. --------------------------------------------------------------------------------------------------------------------------------------------------- Orkestra es un instituto de investigación para el estudio de la competitividad y el desarrollo territorial desde sus distintas líneas de investigación con tres objetivos: • Generar conocimiento en competitividad regional • Propiciar la mejora del bienestar de los ciudadanos • Contribuir a la mejora de la competitividad del País Vasco El equipo de Orkestra impulsa una investigación transformadora que se traduce en el análisis, la reflexión, la evaluación y la propuesta de acciones, de manera permanente, orientadas a aportar respuestas innovadoras para la resolución de los retos planteados, a la vez que se adquiere conocimiento investigador.

Health Engineering is a technology-based newly established company that emerges as a Spin Off of the University of Jaen in order to obtain in the short-term the CE marking as a biomarker for the early detection and monitoring of Multiple Sclerosis. This biomarker that we intend to turn in a diagnostic and monitoring standard is called FractalMed and would be the first commercial technology to determine the Fractal Dimension 3D applied to the diagnosis and monitoring of neurodegenerative diseases. Once obtained the CE marking a reference value for the early diagnosis and monitoring of the disease progression and the response to treatment will be stablished, enabling early interventions with consequent further reduction in the number of outbreaks and improved quality of life for patients. FractalMed has already done the proof of concept and clinical validation demonstrating in a cohort of patients that the Fractal Dimension can be applied as a criterion aid in early diagnosis and monitoring of Multiple Sclerosis. More information; www.fractalmed.com